Investor Relations


Relational Investors' Ralph Whitworth describes how bad capital allocation decisions get “baked into the system,” why he expects the technology sector to provide fertile ground for new investments, which regulatory reform he'd love to see enacted, and why he sees significant upside potential in National Semiconductor, Baxter, Genzyme and MetLife.

If you are a subscriber, log in to access the issue and bonus archive: